🚀 VC round data is live in beta, check it out!
Danaher Valuation Multiples
Discover revenue and EBITDA valuation multiples for Danaher and similar public comparables like Stryker, Medtronic, Intuitive Surgical, Boston Scientific and more.
Danaher Overview
About Danaher
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
Founded
1986
HQ
Employees
60.0K
Website
Financials (LTM)
EV
$161B
Danaher Financials
Danaher reported last 12-month revenue of $25B and EBITDA of $8B.
In the same LTM period, Danaher generated $15B in gross profit, $8B in EBITDA, and $6B in net income.
Revenue (LTM)
Danaher P&L
In the most recent fiscal year, Danaher reported revenue of $25B and EBITDA of $8B.
Danaher expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $25B | XXX | $25B | XXX | XXX | XXX |
| Gross Profit | $15B | XXX | $15B | XXX | XXX | XXX |
| Gross Margin | 59% | XXX | 59% | XXX | XXX | XXX |
| EBITDA | $8B | XXX | $8B | XXX | XXX | XXX |
| EBITDA Margin | 31% | XXX | 31% | XXX | XXX | XXX |
| EBIT Margin | 28% | XXX | 28% | XXX | XXX | XXX |
| Net Profit | $6B | XXX | $6B | XXX | XXX | XXX |
| Net Margin | 23% | XXX | 23% | XXX | XXX | XXX |
| Net Debt | — | — | $14B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Danaher Stock Performance
Danaher has current market cap of $146B, and enterprise value of $161B.
Market Cap Evolution
Danaher's stock price is $206.00.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $161B | $146B | 0.0% | XXX | XXX | XXX | $7.90 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDanaher Valuation Multiples
Danaher trades at 6.5x EV/Revenue multiple, and 20.6x EV/EBITDA.
EV / Revenue (LTM)
Danaher Financial Valuation Multiples
As of April 2, 2026, Danaher has market cap of $146B and EV of $161B.
Equity research analysts estimate Danaher's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Danaher has a P/E ratio of 25.6x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $146B | XXX | $146B | XXX | XXX | XXX |
| EV (current) | $161B | XXX | $161B | XXX | XXX | XXX |
| EV/Revenue | 6.5x | XXX | 6.5x | XXX | XXX | XXX |
| EV/EBITDA | 20.6x | XXX | 20.9x | XXX | XXX | XXX |
| EV/EBIT | 22.8x | XXX | 23.2x | XXX | XXX | XXX |
| EV/Gross Profit | 10.9x | XXX | 11.1x | XXX | XXX | XXX |
| P/E | 25.6x | XXX | 26.1x | XXX | XXX | XXX |
| EV/FCF | 29.9x | XXX | 30.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Danaher Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Danaher Margins & Growth Rates
Danaher's revenue in the last 12 month grew by 5%.
Danaher's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.2M for the same period.
Danaher's rule of 40 is 36% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Danaher's rule of X is 43% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Danaher Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Margin | 31% | XXX | 31% | XXX | XXX | XXX |
| EBITDA Growth | 7% | XXX | 7% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 36% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 43% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| R&D Expenses to Revenue | 7% | XXX | 7% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 40% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Danaher Public Comps
See public comps and valuation multiples for other Medical Devices and Laboratory Services comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Stryker | XXX | XXX | XXX | XXX | XXX | XXX |
| Medtronic | XXX | XXX | XXX | XXX | XXX | XXX |
| Intuitive Surgical | XXX | XXX | XXX | XXX | XXX | XXX |
| Boston Scientific | XXX | XXX | XXX | XXX | XXX | XXX |
| Thermo Fisher Scientific | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Danaher M&A Activity
Danaher acquired XXX companies to date.
Last acquisition by Danaher was on XXXXXXXX, XXXXX. Danaher acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Danaher
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialDanaher Investment Activity
Danaher invested in XXX companies to date.
Danaher made its latest investment on XXXXXXXX, XXXXX. Danaher invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Danaher
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Danaher
| When was Danaher founded? | Danaher was founded in 1986. |
| Where is Danaher headquartered? | Danaher is headquartered in United States. |
| How many employees does Danaher have? | As of today, Danaher has over 60K employees. |
| Who is the CEO of Danaher? | Danaher's CEO is Rainer M. Blair. |
| Is Danaher publicly listed? | Yes, Danaher is a public company listed on NYSE. |
| What is the stock symbol of Danaher? | Danaher trades under DHR ticker. |
| When did Danaher go public? | Danaher went public in 1978. |
| Who are competitors of Danaher? | Danaher main competitors are Stryker, Medtronic, Intuitive Surgical, Boston Scientific. |
| What is the current market cap of Danaher? | Danaher's current market cap is $146B. |
| What is the current revenue of Danaher? | Danaher's last 12 months revenue is $25B. |
| What is the current revenue growth of Danaher? | Danaher revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of Danaher? | Current revenue multiple of Danaher is 6.5x. |
| Is Danaher profitable? | Yes, Danaher is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Danaher? | Danaher's last 12 months EBITDA is $8B. |
| What is Danaher's EBITDA margin? | Danaher's last 12 months EBITDA margin is 31%. |
| What is the current EV/EBITDA multiple of Danaher? | Current EBITDA multiple of Danaher is 20.6x. |
| What is the current FCF of Danaher? | Danaher's last 12 months FCF is $5B. |
| What is Danaher's FCF margin? | Danaher's last 12 months FCF margin is 22%. |
| What is the current EV/FCF multiple of Danaher? | Current FCF multiple of Danaher is 29.9x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.